Procurement News - Latest Tenders News & Updates

Get latest Procurement news & updates on Bid Detail. Set Alert for Upcoming Global procurement News & New Tender News worldwide. Search International & Global Procurement News & Tender news on Bid Detail.

1.

Guangxis seventh batch of direct online procurement and low-cost drug replenishment

Medical Network September 3 Each manufacturer: According to the "Notice on Carrying out the Work of Drug Recording and Purchasing in Guangxi Medical and Health Organizations " (Guo Wei Yao Zh ......

  • China
  • services
  • 03 Sep 2018
view notice less notice
Description Medical Network September 3 Each manufacturer: According to the "Notice on Carrying out the Work of Drug Recording and Purchasing in Guangxi Medical and Health Organizations " (Guo Wei Yao Zheng Fa [2017] No. 1), the 2015 Guangxi Pharmaceutical Direct Online Purchase (seventh batch) and low-cost medicine supplements are now underway. For the procurement work of the network, the relevant matters are notified as follows: First, the scope of procurement In 2015, the direct purchase of Guangxi Pharmaceuticals (the seventh batch) does not include the drugs in the bidding procurement catalogue in principle (but includes the compound patents and exclusive varieties in the bidding procurement catalogue), and the first to fourth batches of direct-hanging catalogues. The varieties that have been linked to the network, the direct procurement of Guangxi medicines in 2015 (the fifth and sixth batches) and the low-cost medicines supplemented the network to purchase the varieties that have been successfully decrypted, the national negotiating drugs and the national designated production catalogue drugs. The purchase of low-cost medicines and supplementary nets includes the list of low-cost drugs published by the National Development and Reform Commission and the list of supplemented low-priced drugs in Guangxi, excluding the varieties that have been linked to the net. Second, the network procurement scope description (1) One of the dosage forms of freeze-dried, solvent-crystallized powder injection or ordinary powder injection was involved in the centralized procurement of low-cost drugs commonly used in Guangxi Zhuang Autonomous Region in 2014. These three dosage forms can no longer participate in the seventh batch of direct nets and Low-cost medicines are supplemented by net purchases. (2) If the seventh batch of drugs purchased directly from the Internet is included in the negotiating procurement catalogue, the relevant drugs will be deleted from the direct-hanging procurement catalogue and entered into the negotiating procurement catalogue. (3) The drugs that participate in the purchase of low-cost medicines and supplemented the nets shall be implemented in accordance with the relevant policies of low-cost medicines. Third, review and quotation Anyone who participates in the procurement of Guangxi Pharmaceuticals Direct Online Purchase (seventh batch) and low-cost medicine supplemented net purchases must submit product information maintenance (except for those that have been submitted and do not need to be updated), qualification review, product declaration, Information confirmation and quotation. If you need to maintain enterprise information, you can save it after maintenance and do not need to submit it. (1) Time schedule. 1. The time for the manufacturer to receive the account number and password is from September 13, 2018 to September 20, 2018. 2. The time for applying for the increase of drugs, application for review and rejection, and modification of the production enterprise association shall be from September 13, 2018 to September 25, 2018. 3. The manufacturer maintains product information from September 13, 2018 to September 30, 2018. 4. The time for the manufacturer to submit the qualification materials is from September 13, 2018 to October 10, 2018. 5. Other work schedules will be announced separately. All manufacturers are requested to pay attention to online notices at all times and complete the work in strict accordance with the prescribed time. (2) Work process. 1. Receive the drug declaration system account password. (1) If the manufacturer of the existing drug declaration system account needs to participate in the audit quotation, the original account password can be used to log in to the drug declaration system to maintain the qualification and product information of the enterprise, and no need to re-acquire the account password. (2) The manufacturer who has not received the drug declaration system account receives the account password according to the requirements of Annex 1, and each manufacturer can only receive one account password. (3) For the manufacturer of the forgotten drug application system account password, the password initialization shall be carried out according to the relevant requirements of the “Service Guide” of the homepage of the centralized procurement of medicines in Guangxi Zhuang Autonomous Region, without re-acquiring the account password. 2. Maintain corporate qualifications and product information. (1) If you need to maintain the company information, you can save it after maintenance, no need to submit. (2) Any manufacturer who intends to participate in this audit quotation should enter the drug declaration system to maintain or update product information and submit it before 23:59 on September 30, 2018 (except for those that have been submitted and do not need to be updated). The drug declaration system operation manual is downloaded from the latest download page of the homepage of the centralized procurement of medicines in Guangxi Zhuang Autonomous Region. (3) If the product information has been submitted in the drug declaration system and there is no need to update it, the manufacturer can directly submit the paper and materials of the enterprise and product for qualification review. (4) If the manufacturer fails to inquire about the actual production enterprise when maintaining imported or imported sub-packaged products, please contact the production enterprise in accordance with the requirements of Annex 1 before 17:30 on September 25, 2018. (5) If the product declaration system has been submitted but needs to be updated or modified, the authorized person will use the original ID card to submit the “Rejection of Application for Rejection” (see Annex 2) at 17:30 on September 25, 2018. Before, submit it to the front desk of the second floor of Taoyuan Office District of Guangxi Public Resource Trading Center, and log in to the drug declaration system before 23:59 on September 30, 2018 to maintain and submit product information for the data to be modified. (6) When the product information is maintained, if the drug information is not available in the drug declaration system, please apply for additional drug information before 17:30 on September 25, 2018, and log in before 23:59 on September 30, 2018. The drug declaration system maintains and submits product information for the added drugs. To apply for the increase of drug information, you need to provide the “Application for Adding Drug Information” (see Attachment 3), the drug registration approval form and the manual (copy, scan, and content must be clear) with the official seal of the manufacturer, and the manufacturer’s client ( Not limited to the authorized person, no need to submit the power of attorney) to the front desk of the second floor of Taoyuan Office District of Guangxi Public Resource Trading Center, do not accept fax and post. 3. Qualification review. The qualification audit is conducted by means of centralized audit. After the manufacturer maintains and submits the product information (except for the original submitted and does not need to be updated), the authorized person will use the original ID card at 17:30 on October 10, 2018. Submit the information to the front desk of the second floor of Taoyuan Office District of Guangxi Public Resource Trading Center before submitting the instructions according to the qualification documents (see Annex 4). After the qualification review, each manufacturer is required to log in to the “Product Information” of the drug declaration system to check the product information review results of the company, and provide corresponding supplementary materials according to the “Review Reasons for Failure”. Additional materials will be announced at any time, and all manufacturers are requested to pay attention to online notices. 4. Online declaration. (1) The drugs that participate in the direct online registration and the low-cost drug supplement online registration must be the drugs being produced, and ensure that they can be supplied on time and in quantity after the finalists. (2) After the qualification review is passed, the manufacturer shall declare it in the drug declaration system within the specified time (subject to further notice), and the drugs that participate in direct online procurement and low-cost drug supplementation will be subject to online declaration. Drugs that have not been onlinely declared within the specified time are deemed to have waived their participation in this direct online procurement and low-cost drug replenishment. (3) The same variety (same production enterprise, common name, same dosage form, same specification) can only be allowed to participate in the declaration, but multiple conversion ratios can be declared. (4) Any application for the prohibition of declarations listed in the relevant documents such as the bad records of Guangxi pharmaceutical machinery procurement and the record of commercial bribery, and the national and Guangxi drug quality announcements since 2014, the drug manufacturers are not allowed to participate in this hang-up. Online purchase. 5. Information confirmation. The drug information declared by the manufacturer must be confirmed online information within the specified time. The drug information cannot be modified after confirmation. The drug that has not been confirmed by the information is considered as a waiver. In the end, the medicines that are directly linked to the net and the low-cost medicines are added to the medicines that complete the information confirmation. 6. Quote. (1) Principle of quotation. 1 All direct hanging nets and low-cost medicines supplemented with net medicines need to be quoted online (the drugs that complete the online information confirmation can be quoted online). 2 Quoted by the manufacturer. The quotation shall include the shelf delivery price, including all taxes and fees, ie the actual supply price of the manufacturer to the purchaser. 3 Decrypt all quote information. (2) Quotation requirements. 1 The price quoted by the manufacturer refers to the supply price that can be supplied to the medical and health institution, and the price quoted includes the delivery fee. 2 Quotes use currency and unit: RMB (yuan), the quotation is reserved to 2 decimal places (ie 0.01). 3 When quoting, the manufacturer quotes the quantity of the packaged product of the actual hanging net. In principle, oral preparations are quoted by the approved packaging unit (such as boxes, bottles, bags, plates, etc.); injections are provided in the form of bottles, bottles, bags, etc.; in Chinese patent medicines and external preparations, pastes, films, patches, etc. Basic packaging quotation; latex, gel, eye drops, nose drops, ear drops, ointments, eye ointments, sprays, aerosols, etc. in external preparations. (3) Quotation method. The manufacturer makes an online quote after the information is confirmed. The manufacturer cannot quote "0" for each quotation, and the quotation is "0" for the quotation. Not quoting is considered as abandoning direct hanging nets and low-cost medicines to supplement the net. 7. Decryption. After the quotation is over, a unified bid opening and decryption will be implemented. The decryption work is operated by the public resource trading center of the autonomous region, and the manufacturer does not need to decrypt it by itself. (3) Precautions. 1. The audits offer only accept domestic producers (include repackaging of imported drugs of domestic sub-packaging business) and foreign manufacturers of the total domestic agents (no domestic distributor, accept applications only an agent, and they The area of ??the agent must include the area in Guangxi. If the company is declared by the group company, the subsidiaries and branches it represents cannot be declared separately. Each subsidiary of the group head office with independent legal personality may choose to declare in the group head office or in a separate subsidiary, but only one declaration can be selected. The branch company of the group head office does not have the status of independent legal person. It is declared by the group head office. The group head company can authorize each branch company to be responsible for the direct purchase of the net in Guangxi in 2015 (or the purchase of low-cost medicines). Related work. 2. Enterprises with the following behaviors will be reviewed as not passing. (1) Violation of laws and regulations in the centralized bidding and procurement of drugs shall be punished by the Food and Drug Administration of the autonomous region and within the penalty period. (2) Since 2012, it has been determined by law enforcement agencies that enterprises have engaged in commercial bribery cases. (3) The manufacturers "business license", "drug business license" or "drug production license", GMP or GSP certification is temporarily suspended or revoked by the competent authority. (4) Failure to pass the market entity credit information disclosure system to submit an annual report to the industrial and commercial authorities, and publicize it to the public. (5) Enterprises that have produced fake drug records since 2012 will not accept their registration. The production of counterfeit drug records shall be based on the “Administrative Punishment Decision” of the Food and Drug Administration and Administration (the “Administrative Punishment Decision” shall be stamped with the official seal of the provincial food and drug supervision and administration department). (6) According to the “Interim Measures for the Supervision and Administration of Centralized Purchasing of Medical Institutions in Guangxi Zhuang Autonomous Region” (Guowei Regulations [2008] No. 54) and other documents, for the 2010 medical institutions in Guangxi ) Centralized procurement of companies with a record of bad behavior, accumulated 5 times or more. 3. After the product information is submitted, it cannot be modified. Please check that the verification is correct and then save and submit. The product information in the “unsubmitted” status cannot be reviewed. 4. After the product information is submitted, the paper information must be submitted and the product declaration and information confirmation can be carried out after the approval. The products that have not confirmed the information cannot participate in the quotation. 5. When the qualification review, the enterprise qualification and product qualification are reviewed, but the “enterprise information” item in the reporting system is not subject to manual operation, as long as the product information is approved. 6. If it is necessary to change the authorized person, it shall be handled in accordance with the relevant requirements of the “Guide to Work” on the homepage of the centralized procurement of medicines in Guangxi Zhuang Autonomous Region. Attachment: 1. Information and requirements for the manufacturer to receive the account password 2. Product Information Review Rejection Letter 3. Increase drug information application 4. Qualification document submission instructions 5. "Two-vote system" commitment letter submission instructions Guangxi Zhuang Autonomous Region Public Resource Trading Center Centralized Purchasing Department for Medicines and Medical Devices
Industry services
Source http://news.pharmnet.com.cn/news/2018/09/03/506452.html
2.

Arianespace to launch ADM-Aeolus

Arianespace has signed a contract with the European Space Agency (ESA) to launch the ADM-Aeolus satellite, a key mission within the scope of Europe’s Earth Explorer program. ADM-Aeolus will provide ......

  • France
  • Airports & Aviation
  • 15 Oct 2016
view notice less notice
Description Arianespace has signed a contract with the European Space Agency (ESA) to launch the ADM-Aeolus satellite, a key mission within the scope of Europe’s Earth Explorer program.

ADM-Aeolus will provide global observations of 3D wind profiles from space, enabling scientists to refine the currently known characteristics and improve techniques for modeling and analyzing the Earth’s atmosphere. This mission will make a direct contribution to improving the quality of weather forecasts and climatology research. The ADM-Aeolus mission is named after the mortal designated by the gods in Greek mythology as the keeper of the winds.

ADM-Aeolus will weigh about 1,400 kg at launch, and will be injected into Sun-synchronous orbit at an altitude of 320 km. It comprises three modules:

· Aladin (Atmospheric Laser Doppler INstrument), a direct-detection lidar (a laser “radar”) incorporating measurements of scattering from aerosols and water droplets (“Mie”) and molecular scattering (“Ray-leigh”), to provide 3D images of wind profiles.
· A platform based on that used for the Mars Express spacecraft.
· Solar array.

Airbus Defence and Space is prime contractor for the ADM-Aeolus mission, and is also in charge of the Aladin in-strument.

The satellite will be launched from the Guiana Space Center, Europe’s spaceport in Kourou, French Guiana, during the second half of 2017, using a Vega light launch vehicle.

Following the contract signature, Stéphane Israël, Chairman and Chief Executive Officer of Arianespace, said: “We are both proud and honored to be chosen once again for a European space mission, which will make a major scientific contribution to our planet. I would like to extend my warm thanks to ESA’s Earth observation directorate for their expression of trust. This latest contract is further recognition of the quality and reliability of the launch services offered by Arianespace and our light launcher, Vega.
Industry Airports & Aviation
Source http://spaceref.com/news/viewpr.html?pid=49414
3.

Masdar and MIT researchers develop device that makes steam from sunlight

Researchers at Abu Dhabi’s Masdar Institute and the Massachusetts Institute of Technology (MIT) have collaborated to create a device that makes steam from the sun, all without the use of solar panels. ......

  • United Arab Emirates
  • Energy & Power
  • 03 Sep 2016
view notice less notice
Description Researchers at Abu Dhabi’s Masdar Institute and the Massachusetts Institute of Technology (MIT) have collaborated to create a device that makes steam from the sun, all without the use of solar panels.

Using bubble wrap and plastic foam, the team of researchers developed a solar-conversion system that floats on water. The device converts 20 per cent of the solar energy captured into steam.

"The technology is particularly suited for the UAE’s dusty climate, as it fully uses the entire spectrum of sunlight for thermal applications rather than just the direct portion, which can be hindered by aerosols," said TieJun Zhang, an assistant professor of mechanical and materials engineering at Masdar Institute.

However, the technology is in its nascent stages, according to Steve Griffiths, the vice president for research and associate provost of Masdar Institute. While the device has been proven to generate steam, there will need to be further research and development on the ways in which it can be utilised.

"Right now this is a great scientific finding in the direction of applications that we really care about, and now we just need to put the engineering behind it to figure out the market to make this applicable," he said.

The first deployment and commercialisation will come after researchers pinpoint the area in which this will be best used, whether it is in desalination or even medical sterilisation.

However, another winning factor with the device is the absence of solar panels, which on average make up about 30 to 40 per cent of the total cost for solar photovoltaic projects.

The technology is composed of a floating sponge that has a light absorber, which is in between bubble wrap and foam. The receiver soaks up water and evaporates it, producing a steady flow of steam.

"This project is an excellent demonstration of how international collaboration and use-inspired research can yield cutting-edge scientific findings that have direct application to the sectors that are at the core of the UAE’s continued evolution toward an innovation and knowledge-based economy," Mr Griffiths said.
Industry Energy & Power
Source http://www.thenational.ae/business/energy/masdar-and-mit-researchers-develop-device-that-makes-steam-from-sunlight?
4.

Wood fuel plan to cut plane CO2 branded as 'pipe dream'

Plans to cut airline CO2 using greener jet fuels made from waste wood have been dismissed as a "pipe dream" by environmentalists. Several high octane, waste-based biofuels are being tested by airli ......

  • United States
  • Environment
  • 02 Sep 2016
view notice less notice
Description Plans to cut airline CO2 using greener jet fuels made from waste wood have been dismissed as a "pipe dream" by environmentalists.

Several high octane, waste-based biofuels are being tested by airlines as a way of curbing CO2.

UN officials are set to endorse these fuels as a key part of global plans to stabilise aviation emissions by 2020.

But critics say the plans are unrealistic and airlines are not taking the issue seriously.

Contested airspace

One of the big failures of the Paris climate agreement, adopted in December 2015, is that it doesn't cover emissions from shipping or aviation.

The scale and impact of carbon from the booming airline business is heavily contested. The industry points out that in 2015 only 2% of human emissions of CO2 came from aircraft.

Environmentalists point out that this doesn't include the warming impact of contrails or other gases and aerosols. They believe the true impact is about 5%.

Earlier this year, the International Civil Aviation Authority (ICAO), the UN body that regulates this sector, produced a report that predicted a three-fold increase in emissions from airplanes by 2050 if nothing is done to restrict carbon.

ICAO has developed a long term plan that it says will ensure that, by the middle of the century, aviation emissions will be half of what they were in 2005.
One of the key parts of that plan is green jet fuel.

Since Virgin Atlantic flew the first flight powered partly by biofuel in 2008, there have been dozens of tests with many different types of alternative jet fuels, often made from oil seed crops or animal fats.

But in the US earlier this year, the Federal Aviation Authority gave the go-ahead to a new fuel making process that some people believe will be a game changer for greener flying.

The new biofuel is made from a type of alcohol called isobutanol, which occurs naturally in the fermentation process and can be found in many items including bread and scotch whiskey.

Pine scented soup

At a large, warm and sweet smelling industrial facility in St Joseph's, Missouri, fermenting tanks three stories tall contain a swirling mixture of wood pulp, water and enzymes.

The engineers here call the liquid, a "broth", and it's from pine-scented soup that isobutanol is extracted.

"It's like making a hot toddy, it has a bit of an alcoholic smell to it but you can still smell the undertones of the pine feedstock in the fermentation," said Andrew Hawkins from Gevo, the company that has been licensed to make jet fuel using this new method.

The enzymes are used to extract the sugars from the pine. Genetically modified yeast then deliver the isobutanol from the sugars. By this stage, the smell of pine has long departed and the clear liquid remaining has the breathtaking whiff of a high-octane fuel.

One more refining step, at another facility, is required to complete the process.

What's making airlines excited about using isobutanol based fuel is the fact that it is much more powerful than ethanol, the current biofuel of choice for transport.

Another attraction is that unlike, ethanol, jet fuel made from isobutanol can be carried and mixed in the same pipes and fuel trucks as petroleum products.

By using forest residue, supporters believe the new fuel can make a real and sustainable difference to airline carbon emissions as trees soak up CO2 as they grow and it is only the waste from their harvesting that's used in production.

"We are short cutting mother nature and sucking carbon directly out of the atmosphere, that maybe yesterday's plane put into the atmosphere," Andrew
Hawkins told BBC News.

"We then create sugars via these trees and then turn that back into fuel."

A question of cost?

Gevo say they are planning to increase production to around 1 million gallons this year.

The company believe they can reduce the cost of production to around $3 a gallon - but that is still around $1.80 more than the current market price of
petroleum based jet fuel.

Isobutanol made from corn is now being been used in test flights by Alaska Airlines in blends of up to 30% with regular fuel.

But whether they are made from wood waste or corn, the financial cost of these new fuels are likely to prove a major problem according to environmentalists.

"They are far too expensive, and they are not delivering the emissions reductions that would justify the investment," said Bill Hemmings of campaign group Transport & Environment.

"The new fuels are two or three times the cost of existing jet fuels, no-one in their right mind would pay that price. People continue to bang that drum about new biofuels, but they are not going to deliver. It's all fairytale stuff."

Attempts to regulate airline emissions have proved very difficult as countries haven't been able to agree on the ways of measurement and responsibility. For example, if an airplane owned by a Middle Eastern airline flies from a poor African country to a poor Asian destination, who should "own" these emissions?
ICAO believe they have found a way forward that would allow airlines to offset emissions in the future by purchasing credits from certified reduction schemes, such as tree planting.

But their long-term goal of halving the level of 2005 emissions by 2050 depends on a rapid uptake of green fuels.

Critics say that this is impossible - it would require around 170 large scale bio-refineries to be built every year between 2020 and 2050, at a cost of up to $60bn a year.

Flying gorillas?

As well as biofuels, UN officials meeting in Montreal in September will also announce tougher standards for new aircraft designs to curb CO2 that will come into force in 2028. Green campaigners say this approach is "incredibly weak".

They say that around 15% of aircraft flying today perform better than these future criteria.

Real change, they argue, won't come through these vague international efforts. They believe that the key to solving the problem lies in the US.

"The US is the 800 pound gorilla of carbon pollution in the sky," said Vera Pardee a lawyer with the Centre for Biological Diversity.

"More than 30% of all international carbon pollution comes from the United States.

"It is the duty of the US to get us out of this problem. If the US Environmental Protection Agency were to adopt meaningful standards then the international
community will follow.

"The airplane manufacturers are not stupid, they need to meet the demands of their markets, when a regulation goes into effect for one of their major markets, that will be the catalyst to cause emissions to finally be handled correctly and come down."
Industry Environment
Source http://www.bbc.com/news/science-environment-37108962

Filter Procurement News

Top